Promising Plasmid DNA Vector Based on APTES-modified Silica Nanoparticles
Tuck-yun Cheang,Bing Tang,An-wu Xu,Guang-qi Chang,Zuo-jun Hu,Wei-ling He,Zhou-hao Xing,Jian-bo Xu,Mian Wang,Shen-ming Wang
DOI: https://doi.org/10.2147/ijn.s28267
IF: 7.033
2012-01-01
International Journal of Nanomedicine
Abstract:Nanoparticles have an enormous potential for development in biomedical applications, such as gene or drug delivery. We developed and characterized aminopropyltriethoxysilane-functionalized silicon dioxide nanoparticles (APTES-SiNPs) for gene therapy. Lipofectamine® 2000, a commonly used agent, served as a contrast. We showed that APTES-SiNPs had a gene transfection efficiency almost equal to that of Lipofectamine 2000, but with lower cytotoxicity. Thus, these novel APTES-SiNPs can achieve highly efficient transfection of plasmid DNA, and to some extent reduce cytotoxicity, which might overcome the critical drawbacks in vivo of conventional carriers, such as viral vectors, organic polymers, and liposomes, and seem to be a promising nonviral gene therapy vector.